Acute hemolytic transfusion reactions (AHTRs) may occur when either incompatible RBCs or large amounts of incompatible plasma are transfused, which can lead to antibody–antigen binding in the recipient. AHTRs can lead to minimal hemolysis with no clinical sequelae, or can…
Transfusion of blood products can lead to number of adverse events and outcomes in recipients, ranging from subclinical infection with a virus that can remain undiagnosed for decades, to acute immune hemolysis or acute septic reaction resulting in rapid onset…
Patient blood management (PBM) is the term given to the appropriate use of blood transfusion to optimize patient care. Patient-centric approach is its core principle ( Fig. 59.1 ). PBM is “transfusing the right product in the right dose to…